Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 22 (RPL31P22) is a noncoding, processed pseudogene related to the ribosomal protein L31 gene. It does not produce a functional protein and is not involved in cellular processes directly. Pseudogenes like RPL31P22 are typically classified as "other" in molecular target families since they derive from protein-coding genes but have lost coding capability due to evolutionary changes[1][3]. Consequently, RPL31P22 is not targeted by therapeutic agents and has no documented role in disease or drug response. If information on a ribosomal protein L31 target is necessary, refer to the functional gene RPL31 (component of the 60S ribosomal subunit)[4][5][7]. If you need structured information about the functional ribosomal protein L31 (not the pseudogene), the canonical name would be 60S ribosomal protein L31 (abbreviation: RPL31), which is a bona fide constituent of the ribosome and does have disease associations and biological functions[4][5][7][6]. However, the target asked about here (RPL31P22) is specifically a pseudogene and generally considered not a functional molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 22 (RPL31P22).